Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Revenue Growth (5y) (2017 - 2026)

Analysis

Iqvia Holdings (IQV) Revenue Growth (5y) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.90%
Mar 31, 2026 4.02%
Dec 31, 2025 5.76%
Sep 30, 2025 8.03%
Jun 30, 2025 9.77%
Mar 31, 2025 6.81%
Dec 31, 2024 6.45%
Sep 30, 2024 7.07%
Jun 30, 2024 6.84%
Mar 31, 2024 6.84%
Dec 31, 2023 7.55%
Sep 30, 2023 7.57%
Jun 30, 2023 7.75%
Mar 31, 2023 7.34%
Dec 31, 2022 8.20%
Sep 30, 2022 7.63%
Jun 30, 2022 8.50%
Mar 31, 2022 8.62%
Dec 31, 2021 13.24%
Sep 30, 2021 24.45%